Assessing antiretroviral therapy success in HIV/AIDS morbidity and mortality trends in Brazil, 1990-2017: an interrupted time series study

Int J STD AIDS. 2021 Feb;32(2):127-134. doi: 10.1177/0956462420952989. Epub 2020 Dec 20.

Abstract

To describe the trends of HIV/AIDS metrics related to the burden of disease for Brazil between 1990 and 2017 we conducted a timeseries analysis for HIV/AIDS indicators by extracting data from the Global Burden of Disease study. We calculated traditional prevalence, incidence and mortality rates, the number of years lost by HIV-related deaths (YLL) and disability (YLD), and disability-adjusted life years (DALY). We estimated time series models and assessed the impact of highly active antiretroviral therapy (HAART) on the same indicators. In the set of disability-adjusted life years (DALY), the highest weight of its magnitude was due to YLL. There was a decline, especially after 1996, of DALY, mortality and YLL for HIV/AIDS. However, YLD, incidence, and prevalence increased over the same period. Also, the analysis of interrupted time series showed that the introduction of HAART into health policy had a significant impact on indicators, especially for DALY and YLL. We need to assess the quality of life of people living with HIV, especially among older adults. In addition, we need to focus on primary prevention, emphasizing methods to avoid infection and public policies should reflect this.

Keywords: Epidemiology applications; HIV/AIDS; burden of diseases; health statistics/trends; time series.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiretroviral Therapy, Highly Active*
  • Brazil / epidemiology
  • Female
  • Global Burden of Disease / statistics & numerical data*
  • HIV Infections / drug therapy*
  • HIV Infections / mortality*
  • HIV Infections / psychology
  • Humans
  • Interrupted Time Series Analysis
  • Life Expectancy
  • Male
  • Morbidity
  • Quality of Life*
  • Quality-Adjusted Life Years
  • Risk Factors
  • Survival Analysis